A randomized, double-masked, parallel-group, comparative study to evaluate the clinical efficacy and safety of 1% azithromycin–0.1% dexamethasone combination compared to 1% azithromycin alone, dexamethasone 0.1% alone, and vehicle in the treatment of subjects with blepharitis
Kamran Hosseini,1 Richard L Lindstrom,2,3 Gary Foulks,4 Kelly K Nichols5 1InSite Vision, Alameda, CA, 2Minnesota Eye Consultants, 3Department of Ophthalmology and Visual Neurosciences, University of Minnesota Medical School, Minneapolis, MN, 4Department of Ophthalmology and Vision Science, School o...
Enregistré dans:
Auteurs principaux: | Hosseini K, Lindstrom RL, Foulks G, Nichols KK |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a01d9c0fb50c4a5685986f2d35951ed0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A Phase III clinical study to evaluate the efficacy of combined azithromycin and dexamethasone in the treatment of blepharoconjunctivitis
par: Hosseini K, et autres
Publié: (2013) -
Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2
par: Xiang Tong, et autres
Publié: (2021) -
Azithromycin in DuraSite® for the treatment of blepharitis
par: Jodi Luchs
Publié: (2010) -
Low‐Temperature Protonic Ceramic Fuel Cells through Interfacial Engineering of Nanocrystalline BaCe0.7Zr0.1Y0.1Yb0.1O3−δ Electrolytes
par: Jun Gao, et autres
Publié: (2021) -
COMPARISON OF MONTHLY PULSE OF ORAL AZITHROMYCIN WITH DAILY DOXYCYCLINE IN THE TREATMENT OF MODERATE ACNE VULGARIS
par: Muhammad Mudassir, et autres
Publié: (2021)